Rapid cycling bipolar disorder: Literature review on pharmacological treatment illustrated by a case report on ketamine.
ketamine
pharmacological treatment
rapid cycling bipolar disorder
review
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
30
10
2021
accepted:
15
12
2021
pubmed:
19
1
2022
medline:
19
4
2022
entrez:
18
1
2022
Statut:
ppublish
Résumé
Rapid cycling bipolar disorder (RCBD) is defined as four or more affective episodes (depression, mania or hypomania) within 1 year. RCBD has a high point of prevalence (from 10% to 20% among clinical bipolar samples) and is associated with greater severity, longer illness duration, worse global functioning and higher suicidal risk, but there is no consensus on treatment option. The use of several pharmacological agents has been reported (levothyroxine, antipsychotics, antidepressants and mood stabilizers). The main objective of this review was to propose a critical review of the literature and to rank the pharmacological agent using a level of evidence (LEO) adapted from the Center for Evidence-Based Medicine, and to illustrate it with a case report on off-label intravenous ketamine. We conducted a review using the MeSH terms and keywords (bipolar [Title/Abstract]) AND (rapid [Title/Abstract]) AND (cycling [Title/Abstract]) AND (treatment [Title/Abstract]). Alexis Bourla and Stéphane Mouchabac screened 638 documents identified through literature search in Medline (PubMed) or by bibliographic references and 164 abstracts were then analyzed. Nonpharmacological treatments were excluded. Seventy articles were included in the review and divided into six categories: mood stabilizers, antipsychotics, hormonal treatments, ketamine and other pharmacological treatments. Our review highlights the heterogeneity of the pharmacological treatment of RCBD and no clear consensus can emerge.
Identifiants
pubmed: 35041295
doi: 10.1002/brb3.2483
pmc: PMC8865164
doi:
Substances chimiques
Anticonvulsants
0
Antidepressive Agents
0
Antimanic Agents
0
Antipsychotic Agents
0
Ketamine
690G0D6V8H
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2483Informations de copyright
© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
J Psychopharmacol. 2003 Jun;17(2):239-41
pubmed: 12870574
Am J Psychiatry. 1983 Sep;140(9):1255
pubmed: 6614242
J Clin Psychiatry. 2009 Jan;70(1):113-21
pubmed: 19192457
J Clin Psychiatry. 1995 Jul;56(7):330
pubmed: 7615488
Presse Med. 2019 Jun;48(6):609-624
pubmed: 31151849
Brain Behav. 2022 Feb;12(2):e2483
pubmed: 35041295
Biol Psychiatry. 2006 Nov 1;60(9):1020-2
pubmed: 16814257
Biol Psychiatry. 1994 Sep 1;36(5):338-40
pubmed: 7993960
Bipolar Disord. 2012 Nov;14(7):780-9
pubmed: 23107222
BMC Psychiatry. 2019 Dec 2;19(1):378
pubmed: 31791284
Brain Behav Immun. 2015 Jan;43:205-13
pubmed: 25451609
Am J Geriatr Psychiatry. 2010 Mar;18(3):276
pubmed: 20224522
Eur Psychiatry. 2006 Jun;21(4):280-1
pubmed: 16360310
Prim Care Companion CNS Disord. 2018 Sep 6;20(5):
pubmed: 30216712
Encephale. 1997 May-Jun;23(3):209-17
pubmed: 9333552
J Affect Disord. 2008 Jan;105(1-3):305-10
pubmed: 17550787
Clin Endocrinol (Oxf). 1996 Aug;45(2):215-23
pubmed: 8881455
Mol Psychiatry. 2005 May;10(5):456-69
pubmed: 15724143
Brain Behav Immun. 2019 Oct;81:361-373
pubmed: 31255681
Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(2):171-80
pubmed: 2309035
J Clin Psychopharmacol. 2008 Oct;28(5):555-60
pubmed: 18794653
Neuropsychopharmacology. 1994 May;10(3):183-9
pubmed: 7916915
J Clin Psychopharmacol. 1998 Apr;18(2):172-4
pubmed: 9555604
J Clin Psychopharmacol. 1991 Dec;11(6):396-7
pubmed: 1770164
Am J Psychiatry. 1997 Aug;154(8):1171-2
pubmed: 9247416
J Psychiatr Res. 2008 Oct;42(13):1068-75
pubmed: 18262204
Can J Psychiatry. 1993 Apr;38(3 Suppl 2):S57-61
pubmed: 8500080
Bipolar Disord. 2004 Oct;6(5):435-9
pubmed: 15383138
J Clin Psychiatry. 1997 Sep;58(9):383-8
pubmed: 9378688
J Clin Psychiatry. 1990 Nov;51(11):450-5
pubmed: 2121720
Am J Psychiatry. 1996 Sep;153(9):1236
pubmed: 8780440
J Child Adolesc Psychopharmacol. 1999;9(1):51-61
pubmed: 10357518
J Clin Psychopharmacol. 1992 Feb;12(1 Suppl):53S-56S
pubmed: 1541718
Bipolar Disord. 2004 Aug;6(4):329-32
pubmed: 15225152
Encephale. 1996 Nov-Dec;22(6):468-9
pubmed: 10901840
Psychoneuroendocrinology. 1987;12(4):261-70
pubmed: 2821568
Neuropsychopharmacology. 1998 Jun;18(6):444-55
pubmed: 9571653
J Clin Psychopharmacol. 1985 Aug;5(4):229-30
pubmed: 3926833
Can J Psychiatry. 1993 Mar;38(2):137-9
pubmed: 8467440
J Clin Psychopharmacol. 1988 Aug;8(4):275-9
pubmed: 3145291
Bipolar Disord. 2002 Oct;4(5):335-40
pubmed: 12479667
J Clin Psychopharmacol. 1992 Dec;12(6):443-4
pubmed: 1474183
Indian J Psychol Med. 2015 Oct-Dec;37(4):473-4
pubmed: 26702189
Am J Psychiatry. 2005 Nov;162(11):2152-61
pubmed: 16263857
Can J Psychiatry. 2001 Jun;46(5):452-3
pubmed: 11441787
Curr Med Res Opin. 2004 Sep;20(9):1371-6
pubmed: 15383185
J Am Acad Child Adolesc Psychiatry. 1996 Feb;35(2):131-2
pubmed: 8720620
J Clin Psychiatry. 2004 Oct;65(10):1420-8
pubmed: 15491248
Am J Psychiatry. 2021 May 1;178(5):383-399
pubmed: 33726522
Psychiatriki. 2016 Oct-Dec;27(4):253-263
pubmed: 28114089
J Clin Psychiatry. 1997 Dec;58(12):522-7
pubmed: 9448654
J Clin Psychopharmacol. 2003 Aug;23(4):370-6
pubmed: 12920413
Depress Anxiety. 2016 Aug;33(8):698-710
pubmed: 27062450
J Clin Psychopharmacol. 1996 Feb;16(1):87-90
pubmed: 8834431
Clin Neuropharmacol. 2011 Nov-Dec;34(6):224-33
pubmed: 22104634
Clin Neuropharmacol. 2005 May-Jun;28(3):136-8
pubmed: 15965313
J Affect Disord. 2005 Dec;89(1-3):69-77
pubmed: 16253344
Am J Psychiatry. 1990 Apr;147(4):431-4
pubmed: 2107762
Hum Psychopharmacol. 2003 Oct;18(7):559-60
pubmed: 14533138
Arch Gen Psychiatry. 1990 May;47(5):435-40
pubmed: 2184796
Br J Psychiatry. 2013 Apr;202(4):301-6
pubmed: 23099447
Acta Psychiatr Scand. 1991 Jun;83(6):456-9
pubmed: 1882698
J Clin Psychiatry. 2014 Jun;75(6):e578-86
pubmed: 25004199
Biol Psychiatry. 2008 Jan 1;63(1):125-30
pubmed: 17543894
J Clin Psychiatry. 2017 Sep/Oct;78(8):e986-e993
pubmed: 28922589
Asia Pac Psychiatry. 2016 Mar;8(1):98-101
pubmed: 26871425
Gen Hosp Psychiatry. 2003 Jan-Feb;25(1):57-9
pubmed: 12583934
Arch Gen Psychiatry. 1990 May;47(5):427-32
pubmed: 2109970
Acta Psychiatr Scand. 2019 Mar;139(3):227-236
pubmed: 30383306
Am J Psychiatry. 2005 Jul;162(7):1273-80
pubmed: 15994709
J Clin Psychopharmacol. 2007 Feb;27(1):104-6
pubmed: 17224731
J Affect Disord. 2003 Jan;73(1-2):155-61
pubmed: 12507748
Biol Psychiatry. 1996 Sep 1;40(5):382-8
pubmed: 8874839
Int Clin Psychopharmacol. 1988 Apr;3(2):123-9
pubmed: 3397520
Turk Psikiyatri Derg. 2019 Winter;30(4):268-271
pubmed: 32594488
Neuropsychobiology. 2002;45 Suppl 1:20-6
pubmed: 11893873
J Psychopharmacol. 2010 Dec;24(12):1834-6
pubmed: 20142304
Psychiatry Clin Neurosci. 2007 Feb;61(1):130-1
pubmed: 17239053
Am J Psychiatry. 2004 Oct;161(10):1902-8
pubmed: 15465989
Pharmacopsychiatry. 2005 Sep;38(5):225-6
pubmed: 16189752
Int J Clin Pract. 2008 May;62(5):679-87
pubmed: 18373615
Bipolar Disord. 2003 Aug;5(4):300-6
pubmed: 12895208
J Clin Psychiatry. 2000 Nov;61(11):841-50
pubmed: 11105737
Arch Gen Psychiatry. 1982 Mar;39(3):311-2
pubmed: 7065841
Arch Gen Psychiatry. 2003 Sep;60(9):914-20
pubmed: 12963673
Brain Behav Immun. 2012 May;26(4):559-63
pubmed: 22285302
Int J Bipolar Disord. 2018 Jan 20;6(1):4
pubmed: 29352395
Psychopharmacol Bull. 2010;43(4):5-21
pubmed: 21240149
Bipolar Disord. 2018 Nov;20(7):594-603
pubmed: 29869405
Pharmacotherapy. 1987;7(4):130-2
pubmed: 3684732
Neuropsychiatr Dis Treat. 2015 Feb 10;11:339-42
pubmed: 25709457
J Clin Psychopharmacol. 1989 Oct;9(5):382-4
pubmed: 2507592
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1548-9
pubmed: 17630063